Drug Database
Back to search

Switzerland· 56387002

Mestinon retard, Tabletten

A pyridostigmine product containing pyridostigmini bromidum, registered in Switzerland by MEDA Pharmaceuticals Switzerland GmbH and dispensed under Swissmedic category B. The same ATC class is registered in 16 of our 19 countries.

Cat B (Swissmedic)ATC N07AA02

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedMestinon retard, TablettenATCN07AA02REGISTER NO.56387002PACKS LISTED0CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about pyridostigmini bromidumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pyridostigmine is registered in 16 of 19 countries.

Countries holding a registration under ATC N07AA02 (pyridostigmine), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 8 of them publish a price we can compare per daily dose
Search pyridostigmine products by name

Pyridostigmine · ATC N07AA02

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pyridostigmine costs, country by country.

Normalised to the WHO defined daily dose (0.18 g), so markets compare like for like.

  • Switzerland: $2.06 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Pyridostigmine · price per daily dose (0.18 g)

USD · FX 28 Sept 2026

  • CH Switzerland$2.06
  • FR France$1.63
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
pyridostigmini bromidum
Manufacturer
MEDA Pharmaceuticals Switzerland GmbH
Country
Switzerland (CH)
ATC code
N07AA02
ATC class
Pyridostigmine
Defined daily dose
0.18 g, O
Swissmedic category
B
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

106 interactions on record for pyridostigmine.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check pyridostigmine against other medicinesHow interaction checks work

Pyridostigmine · interactions on record

106 records

  • 2 severe
  • 56 moderate
  • 48 info

Most severe, free to view

  • SiponimodL04AA42severe
  • SiponimodL04AE03severe
  • DicycloverineA03AA07moderate
  • PropanthelineA03AB05moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pyridostigmine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pyridostigmine products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Mestinon
  • Belgium · Mestinon
  • Bulgaria · Калимин
  • Czechia · Mestinon
  • Germany · Amindan, Kalymin
  • Denmark · Mestinon, Pyridostigminbromid Orifarm
  • Estonia · Kalymin, Mestinon
  • Spain · Mestinon
  • Finland · Mestinon
  • France · Mestinon, Mestinon Lp
  • United Kingdom (Northern Ireland) · Mestinon, Pyridostigmine Bromide
  • Greece · Mestinon
  • Croatia · Mestinon 60
  • Hungary · Mestinon
  • Ireland · Mestinon
  • Italy · Mestinon
  • Luxembourg · Mestinon
  • Latvia · Kalymin 60 N, Mestinon
  • Malta · Mestinon
  • Netherlands · Mestinon, Mestinon 60
  • Norway · Mestinon
  • Poland · Mestinon, Stygmistanon
  • Portugal · Mestinon
  • Romania · Mestinon
  • Sweden · Mestinon, Pyridostigmin Orifarm
  • Slovenia · Mestinon
  • Slovakia · Mestinon

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4577bcaf-bf30-4294-b8dd-fd9898da9a60
GET /v1/drugs/4577bcaf-bf30-4294-b8dd-fd9898da9a60?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{}
API referenceMCP serverPlans

See everything about pyridostigmine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console